tagrisso
learn about tagrisso® (osimertinib), a targeted treatment option for people with certain types of egfr+ non-small cell lung cancer (nsclc). talk to your doctor to see if tagrisso is right for you.
learn more about tagrisso® (osimertinib), a targeted therapy for the first-line treatment of metastatic egfrm non-small cell lung cancer and for resectable egfrm nsclc.
ADS